Hello! I’m Holly Hartman (she/her)
Faculty at Case Western Reserve University
Check out my work, and get in touch below.
Cancer treatments are being delayed due to COVID-19, but is this always the best option? I built an app to create personalized survival estimates for cancer patients during the COVID-19 pandemic
Many clinical trial designs rely on dichotomous end points. I explore how to allow for continuous outcomes while maintaining trial properties and statistical features.
Observational studies can provide answers to research questions and uses less resources than a randomized clinical trial. Do they provide accurate answers about treatment comparisons?
Hello! I’m Holly Hartman, a Visiting Assistant Professor at Case Western Reserve University.
I received my PhD in biostatistics from the University of Michigan. Go Blue! I have a BS in mathematics and molecular and cellular biology from the University of Puget Sound and an MS in biostatistics from the University of Alabama at Birmingham.
My current work is in methodological improvements for clinical trial design. I also collaborate with clinicians and work to provide better care for patients. I am interested in using statistics to identify solutions to health disparities.
I have also been extensively involved in diversity, equity, and inclusion (DEI) in my research as well as in my service.
For fun, I enjoy crafting ceramics, flying through the air on a trapeze, and hanging out with my dog and cat.